Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections—more commonly known by its acronym, PANDAS—is a term that’s been circulating in pediatric circles for a few decades now, often with a mixture of curiosity, skepticism, and frustration. If you’ve been in practice long enough, chances are you’ve either heard about it from a concerned parent who came in with a printout from Google or you've encountered a kid whose Obsessive-Compulsive Disorder (OCD) symptoms came on like a switch had been flipped. So let’s talk shop—what PANDAS is, what we know, and why it's still a hotly debated diagnosis.

What Is PANDAS? Origins, Criteria, and Proposed Mechanisms

The idea of PANDAS came into the picture in the late '90s when researchers at the NIMH noticed something odd. Some children, often previously healthy, developed sudden and severe obsessive-compulsive behaviors or motor tics after what seemed to be a run-of-the-mill strep infection. The presentation was rapid—overnight, in many cases—and these weren’t mild quirks. We’re talking about full-blown symptoms that could impair daily functioning. The kids were between the ages of three and puberty, and many of them had a relapsing-remitting course, seemingly tied to subsequent strep exposures.

The proposed mechanism? Autoimmunity. The theory rests on the idea that some kids, after a group A strep (GAS) infection, mount an aberrant immune response. Instead of just targeting the bacteria, the antibodies get a little too enthusiastic and start attacking the basal ganglia. It’s a similar concept to what we see in Sydenham chorea—another post-streptococcal complication. In fact, Sydenham chorea has long been known to cause emotional lability, tics, and other neuropsychiatric symptoms. So the jump to PANDAS wasn’t entirely out of left field.

To be considered for a PANDAS diagnosis, a child should meet five criteria: OCD and/or a tic disorder, symptom onset between ages three and puberty, an abrupt and dramatic symptom onset, a temporal relationship with a GAS infection, and neurologic abnormalities during exacerbations—think motor hyperactivity, tics, or choreiform movements. But here's the thing—GAS is common in kids. So are OCD and tics. Sorting out correlation from causation is where the whole thing gets messy.

The pathogenesis theories are fascinating, albeit still speculative. Molecular mimicry is a big contender—essentially, the immune system mistakes the basal ganglia for strep and begins an autoimmune attack. There's also emerging interest in the role of the gut-brain axis and neuroinflammation, with some studies pointing to altered microbiota and increased markers of oxidative stress in affected kids.

PANDAS vs. PANS: The Ongoing Controversy

Despite all of this, the controversy surrounding PANDAS hasn’t died down. Some experts argue that we’re pathologizing normal childhood infections and developmental phenomena. Others feel the condition is underdiagnosed and dismissed too quickly, leaving families desperate and underserved. And let's be real—parents who’ve witnessed their child transform overnight don’t find comfort in ambiguity. Clinicians, on the other hand, are left stuck between wanting to validate parent concerns and following evidence-based practice.

To complicate things, a broader term—PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)—was introduced to include kids with similar presentations but without documented strep infections. PANS opens the door to other infectious or inflammatory triggers, such as Mycoplasma pneumoniae, Lyme disease, or even metabolic disturbances. It’s a more inclusive, albeit more nebulous, diagnostic umbrella.

The data on epidemiology is limited. We don’t really know how common PANDAS is. Some studies suggest it's rare—one found just 13 cases in nearly 100,000 children—but definitions vary, and surveillance methods are inconsistent. What we do know is that some kids clearly have abrupt neuropsychiatric symptom onset linked to strep, and some of them improve with antibiotics. That’s hard to ignore.

Clinical Evaluation and First-Line Management

So, how should we approach these cases? First, a thorough history and exam. Look for that classic sudden onset of OCD behaviors, tics, anxiety, or urinary frequency. If there’s a recent strep infection—or even just high ASO or anti-DNase B titers—it may support the diagnosis. Note that titers can stay elevated for months, so interpreting them can be tricky. Still, if you’re seeing symptom onset or flare-ups that seem tied to a GAS infection, it’s worth taking seriously.

Treatment usually starts with antibiotics for acute GAS infection, the same as you would for strep throat. Azithromycin or a cephalosporin is often preferred in suspected PANDAS cases, especially if penicillins haven’t been effective. There’s also a gray area with prophylactic antibiotics. Some clinicians, especially those aligned with the NIMH approach, will try a season of prophylaxis (usually during winter) to see if it reduces flare-ups. If symptoms abate during prophylaxis, it lends weight to the PANDAS diagnosis. But this strategy isn’t universally endorsed, and concerns about overuse of antibiotics, microbiome disruption, and resistance are real.

As for neuropsychiatric symptoms, standard treatments apply. OCD? Start with selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT). Tics? Behavioral therapy, antipsychotics, or alpha-agonists, depending on severity. The PANDAS label doesn’t change the fact that these kids need the same psychiatric support as anyone else with OCD or tic disorders.

Advanced Therapies, Long-Term Outcomes, and Practice Considerations

What about immunomodulatory treatments like steroids, intravenous immunoglobulin (IVIg), or plasmapheresis? A small number of trials suggest benefit in severe cases, particularly those with strong links to GAS and elevated antineuronal antibodies. But we’re lacking robust, large-scale, controlled studies. Use of these treatments is usually reserved for severe, refractory cases under the care of a specialist—often in consultation with neurology, immunology, or rheumatology.

In terms of long-term outcomes, we just don’t know enough. Some kids seem to recover fully, especially when treated early. Others go on to develop more classic, chronic forms of OCD or tic disorders.

Bottom line? PANDAS sits at the crossroads of infectious disease, psychiatry, neurology, and immunology. It’s uncomfortable because it challenges our frameworks and calls for interdisciplinary cooperation. There’s no doubt some kids fit this mold—they have abrupt neuropsychiatric changes tied to strep and respond to antibiotics. But without definitive biomarkers or consistent pathophysiology, it’s hard to make sweeping generalizations.

Whether you're a believer, a skeptic, or somewhere in between, the key is keeping an open mind. Validate your patients and families, stay curious, and follow the evolving research. Dismissing these children outright—or, conversely, aggressively over-diagnosing without scrutiny—helps no one.

About the Author

Jennifer "Jenny" Huynh, BSN, RN, NCSN, graduated from the University of Massachusetts Lowell (UMass Lowell) and is certified as a school nurse. She has worked as an RN for six years, focusing on school nursing. Currently, Jenny is working on her Master's in Nursing Education and is an Adjunct Instructor at UMass Lowell.

Jenny is an independent contributor to CEUfast’s Nursing Blog Program. Please note that the views, thoughts, and opinions expressed in this blog post are solely those of the independent contributor and do not necessarily represent those of CEUfast. This is not medical advice. Always consult with your personal healthcare provider for any health-related questions or concerns.

If you are interested in learning more about CEUfast’s Nursing Blog Program or would like to submit a blog post for consideration, please visit https://ceufast.com/blog/submissions.</p>